Sigilon Therapeutics, Inc. Current Liabilities
Sigilon Therapeutics, Inc. had Current Liabilities of $25.25 million as of 2023-06-30, per its 10-Q filed 2023-08-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2023-08-07
- 2023-06-30: Liabilities, Current $25.25M.
- 2023-03-31: Liabilities, Current $28.99M.
- 2022-12-31: Liabilities, Current $30.99M.
- 2022-09-30: Liabilities, Current $30.55M.
| Period end | Liabilities, Current |
|---|---|
| 2023-06-30 | $25.25M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $28.99M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $30.99M 10-Q · filed 2023-08-07 |
| 2022-09-30 | $30.55M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $33.32M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $37.05M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $34.89M 10-K · filed 2023-03-14 |
| 2021-09-30 | $40.87M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $44.39M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $34.48M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $47.02M 10-K · filed 2022-03-14 |